Hic-5 promotes invadopodia formation and invasion during TGF-β–induced epithelial–mesenchymal transition

por Pignatelli, Jeanine, Tumbarello, David A., Schmidt, Ronald P., Turner, Christopher E.
Publicado 2012

Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue

por Werner, Ulrich, Korn, Marcus, Schmidt, Ronald, Wendrich, Thomas M., Tennagels, Norbert
Publicado 2014

Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites,...

por Varewijck, Aimee J., Yki-Järvinen, Hannele, Schmidt, Ronald, Tennagels, Norbert, Janssen, Joseph A.M.J.L.
Publicado 2013

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabete...

por Bolli, Geremia B., Hahn, Annke D., Schmidt, Ronald, Eisenblaetter, Tanja, Dahmen, Raphael, Heise, Tim, Becker, Reinhard H.A.
Publicado 2012

Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice

por Brenneis, Christian, Coste, Ovidiu, Schmidt, Ronald, Angioni, Carlo, Popp, Laura, Nusing, Rolf M, Becker, Wiebke, Scholich, Klaus, Geisslinger, Gerd
Publicado 2008

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

por Lucidi, Paola, Porcellati, Francesca, Rossetti, Paolo, Candeloro, Paola, Andreoli, Anna Marinelli, Cioli, Patrizia, Hahn, Annke, Schmidt, Ronald, Bolli, Geremia B., Fanelli, Carmine G.
Publicado 2012

“Omics” data integration and functional analyses link Enoyl-CoA hydratase, short chain 1 to drug refractory dilated cardiomyopathy

por Campbell, Nzali V., Weitzenkamp, David A., Campbell, Ian L., Schmidt, Ronald F., Hicks, Chindo, Morgan, Michael J., Irwin, David C., Tentler, John J.
Publicado 2018